Home
>
National Drug Code (NDC)
>
Ipratropium Bromide and Albuterol Sulfate
Ipratropium Bromide and Albuterol Sulfate - 0487-0201-03 - (Ipratropium Bromide and Albuterol Sulfate)
Drug Information of Ipratropium Bromide and Albuterol Sulfate
| Product NDC: | 0487-0201 |
| Proprietary Name: | Ipratropium Bromide and Albuterol Sulfate |
| Non Proprietary Name: | Ipratropium Bromide and Albuterol Sulfate |
| Active Ingredient(s): | 3; .5 mg/3mL; mg/3mL & nbsp; Ipratropium Bromide and Albuterol Sulfate |
| Administration Route(s): | RESPIRATORY (INHALATION) |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ipratropium Bromide and Albuterol Sulfate
| Product NDC: | 0487-0201 |
| Labeler Name: | Nephron Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076749 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20071231 |
Package Information of Ipratropium Bromide and Albuterol Sulfate
| Package NDC: | 0487-0201-03 |
| Package Description: | 5 POUCH in 1 CARTON (0487-0201-03) > 6 VIAL, SINGLE-USE in 1 POUCH > 3 mL in 1 VIAL, SINGLE-USE |
NDC Information of Ipratropium Bromide and Albuterol Sulfate
| NDC Code | 0487-0201-03 |
| Proprietary Name | Ipratropium Bromide and Albuterol Sulfate |
| Package Description | 5 POUCH in 1 CARTON (0487-0201-03) > 6 VIAL, SINGLE-USE in 1 POUCH > 3 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 0487-0201 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ipratropium Bromide and Albuterol Sulfate |
| Dosage Form Name | SOLUTION |
| Route Name | RESPIRATORY (INHALATION) |
| Start Marketing Date | 20071231 |
| Marketing Category Name | ANDA |
| Labeler Name | Nephron Pharmaceuticals Corporation |
| Substance Name | ALBUTEROL SULFATE; IPRATROPIUM BROMIDE |
| Strength Number | 3; .5 |
| Strength Unit | mg/3mL; mg/3mL |
| Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
